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Abstract. Physical and immunogenic properties of re- 
constituted membranes designed for the presentation of 
tumour-associated antigens (TAA) to the immune system 
are described. Proteins and lipids of crude membranes of 
SL2 routine lymphosarcoma cells were partially solubi- 
lized with octylglucoside. Reconstituted membranes, con- 
sisting mainly of unilamellar vesicles with a diameter of 
0.03-0.15 gm, were formed by detergent removal and 
were purified by floatation in a discontinuous sucrose gra- 
dient to remove non-lipid-bound protein. Subcutaneous 
immunization of syngeneic mice with reconstituted mem- 
branes or with purified reconstituted membranes induced 
protection against an intraperitoneal challenge with 103 
viable SL2 cells. Reconstituted membranes were more im- 
munogenic than crude membranes in immunoprotection 
experiments when compared on the basis of protein dose. 
Detergent removal was required to obtain an immunogenic 
presentation form of SL2 membrane antigens and to avoid 
toxicity associated with the detergent. Reconstitution of 
SL2 membranes in the presence of exogenous phos- 
pholipid slightly increased the fraction of protein that as- 
sociated with the reconstituted membranes. However, the 
immunogenicity of the solubilized membrane TAA was 
not significantly affected by the presence of exogenous 
phospholipid. The reconstitution procedure described may 
be useful in identifying membrane factors required for the 
induction of immune responses against TAA. The versatil- 
ity of the system may be employed to develop safe alterna- 
tives for whole-cell vaccines. 
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Introduction 
Liposomes, membrane-like vesicles containing one or 
more phospholipid (PL) bilayers surrounding aqueous 
compartments, have generated considerable interest as ve- 
hicles for the presentation of antigens to the immune sys- 
tem (reviewed by Bergers et al. [4], Gregoriadis [15] and 
Kersten et al. [23]). As the liposomal characteristics, such 
as charge, bilayer fluidity, particle size and antigen density, 
can be varied, liposomes provide valuable tools to investi- 
gate mechanisms involved in antigen recognition and in- 
duction of immunity. Such properties may be employed 
to prepare tailor-made vaccines for human and veterinary 
use [15]. 
Immune reactions against chemically induced murine 
sarcomas were demonstrated more than three decades ago 
[32]. Antibodies against he autologous tumour in the se- 
rum of cancer patients [29] and tumour-infiltrating lym- 
phocytes in or around the tumour [2] indicate that at least 
some human tumours are recognized by the immune sys- 
tem. However, it has been extremely difficult o exploit he 
immune system for developing strategies for cancer treat- 
ment. One approach isactive specific immunotherapy with 
vaccines containing tumour-associated antigens (TAA). 
The results of clinical studies with turnout vaccines com- 
posed of a combination of adjuvants with irradiated tumour 
cells, tumour cell lysates, or extracted TAA of tumour cells 
(TAA extracts) suggest that these vaccines can slow down 
the progression of some cancers and can increase the sur- 
vival time of patients [7, 19, 27, 36]. 
The TAA responsible for inducing tumour ejection are 
(glyco)proteins or glycolipids expressed on the cell sur- 
face. Crude TAA extracts, prepared by treatment of turnout 
cells with low butanol concentrations or hypertonic KC1 
solutions, for example, can induce protective turnout im- 
munity in murine models [26]. Despite numerous efforts, 
only a limited number of such TAA have been character- 
ized successfully [35]. The potential of.TAA extracts to 
induce immunity is generally decreased compared to ir- 
radiated tumour cells or purified plasma membranes. It is, 
therefore, of interest to investigate the immunogenicity of
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cell-membrane antigens presented in a fashion more simi- 
lar to that of intact cells, that is in a more membrane-like 
structure. When TAA are solubilized by a detergent that 
leaves the hydrophobic part of proteins intact, insertion of 
TAA into a liposome structure may offer possibilities for 
presentation f the antigenic structures. 
As shown in a previous paper [3], protective tumour 
immunity against the weakly immunogenic, spontaneously 
arising SL2 lymphosarcoma c n be induced by immuniza- 
tion of syngeneic mice with reconstituted membranes. Re- 
constituted membranes consist of liposome-like structures 
prepared from cell membrane constituents. They are 
formed by removal of the detergent from solubilized mem- 
brane lipids and proteins. However, it was observed that, 
depending on the detergent used, only 50%-80% of the 
solubilized proteins were associated with the reconstituted 
membranes. This made it impossible to define the exact 
role of the membrane-associated proteins in the induction 
of protection, as only some of the proteins in the vaccine 
were membrane-associated. 
In this study, flee, non-membrane-associated proteins 
present in the reconstituted membranes were separated 
from membrane-associated proteins (purified reconstituted 
membranes), and both fractions were tested for their poten- 
tial to induce tumour immunity. The immunogenicity of
the purified reconstituted membranes was compared to that 
of solubilized membrane antigens. As the protein to PL 
ratio may affect the reconstitution efficiency and the im- 
munogenicity of membrane-presented antigens [10, 38], 
the effect of the addition of exogenous PL to the reconsti- 
tuted membranes on their immunogenic potential was stud- 
ied. Considerable attention was paid to the physical and 
chemical characteristics of the different antigen disper- 
sions used. 
Materials and methods 
Mice. Inbred DBA/2 mice were obtained from IFFA-Credo, France. 
Animals were maintained according to standard conditions in the central 
animal facilities of Utrecht University. Male mice were used at an age of 
2 -  3 months. 
experiments: a non-ionic nature and a high critical micelle concentration 
(the detergent concentration atand above which micelles form). Non- 
ionic detergents generally do not have deleterious effects on the biologi- 
cal activity of proteins. A high critical micelle concentration makes the 
detergent readily dialysable [17]. After incubation for 30 min with OG 
with stirring, non-solubilized material was removed by centrifugation at 
105000g for 45 min. Reconstituted membranes were formed by 
dialysing the supernatant for 48-72 h against at least 100-fold buffer 
volume, with two changes. All these steps were performed on ice or at 
4 ~ C. For each immunization the reconstituted membranes were freshly 
prepared. 
Purification of reconstituted membranes. Reconstituted membranes of
SL2 cells were purified by floatation in a discontinuous sucrose gradient. 
Solid sucrose was added to 3.0 ml membrane suspension i a centrifuge 
tube to a final concentration f 45% (w/w). This suspension was over- 
layed with 5.0 ml 35% (w/w) sucrose in TRIS-buffered saline, and then 
with 1.5 ml TRIS-buffered saline, and was centrifuged for 16 h at 
130000 g. Fractions of 1 ml were collected, starting at the top of the 
gradient. 
To locate membrane-associated proteins in the sucrose gradient, 
membrane proteins devoid of lipids and lipids devoid of membrane 
proteins were isolated from crude membranes of SL2 cells and were run 
in the gradient. 
To obtain membrane proteins devoid of lipids, most of the proteins 
and PL of crude membranes were solubilized by treatment with 2% 
deoxycholate (Sigma Chemical Co., St. Louis, Mo.) in 10 mM 
TRIS/HC1, 140 mM NaC1, pH 8.2. The solubilized membranes were 
passed through aSephadex G-50 column (Pharmacia, Uppsala, Sweden) 
equilibrated with buffered 0.2% deoxycholate (pH 8.2) and fractionated. 
The protein content of each fraction was determined by measuring the 
absorbance at 280 nm, and the PL content was assessed as described 
below. Those protein fractions in which no PL could be detected (con- 
taining more than 90% of the total solubilized proteins) were pooled, 
concentrated byultrafiltration, and dialysed against TRIS-buffered saline 
to remove deoxycholate. Subsequently, these proteins were solubilized in 
OG and subjected to the reconstitution and purification procedures as 
described for reconstituted membranes. 
Lipids devoid of proteins were extracted from crude membranes with 
chloroform/methanol as described before [3]. Lipids were solubilized in 
150 mM OG and subjected to the reconstitution and purification pro- 
cedures as described for reconstituted membranes. 
For immunoprotection studies, fractions 1-3 (referred to as the puri- 
fied reconstituted membranes) and fractions 6-11 (referred to as the 
remaining fraction) of the gradient were pooled and were dialysed over- 
night against TRIS-buffered saline to remove the sucrose. Subsequently, 
the fractions were concentrated by overlaying the dialysis tubes with 
solid polyethyleneglycol 40,000 (Serva, Heidelberg, Germany). The 
whole procedure was performed on ice or at 4 ~ C. 
Tumours. The DBA/2-derived SL2 lymphosarcoma, which arose spon- 
taneously as an ascitic tumour, was used. The tumour was maintained in
syngeneic DBA/2 mice by weekly intraperitoneal (i.p.) passage of 
5 x 105 cells. The tumour grows i.p. as an ascitic tumour and subcu- 
taneously (s. c.) as a solid tumour; about 50% of the animals die from 
tumour growth after i. p. injection of 1 - 10 SL2 cells [11]. 
Trypsin treatment ofsoIubilized membranes. Solubilized membranes ata 
concentration f approximately 0.8 mg protein/ml were incubated with 
103 U/ml bovine pancreas trypsin (Sigma Chemical Co., St. Louis, Mo.) 
for 2 h at 37 ~ C. Reconstituted membranes were obtained by removal of 
the detergent and purified as described above. 
Preparation of reconstituted membranes. Freshly harvested SL2 cells 
were obtained 7 -8  days after transplantation a d were washed three 
times with RPMI-1640 medium (Flow Laboratories, McLean, Va.). 
Crude membranes were isolated from these cells as described before [3]. 
Briefly, tumour cells were disrupted by a freezing/thawing cycle in a 
hypotonic buffer. Cellular debris and nuclei were removed by low-speed 
centrifugation and crude membranes were pelleted by high-speed 
centrifugation. Crude membranes were stored in small aliquots at -70 ~ C 
until use. 
After thawing, crude membranes were partially solubilized by in- 
cubation with 150 mM octylglucoside (OG) (Sigma Chemical Co., St. 
Louis, Mo.) in 10 mM TRIS/HC1, 140 mM NaC1, pH 7.3, at a protein 
concentration f 2.0 mg/ml. This detergent is one of the few detergents 
that combines two characteristics that are very useful for reconstitution 
Preparation of reconstituted membranes with additional exogenous 
phosphoIipid. Purified reconstituted membranes containing additional 
exogenous PL were prepared as follows. A solution of egg L-a- 
phosphatidylcholine type V-E (PtdCho) (Sigma Chemical Co., St. Louis, 
Mo.) and egg phosphatidylglycerol (PtdGro) (a gift from Nattermann 
GmbH, Cologne, Germany) (9 : 1 ratio) in a chloroform/methanol mix- 
ture (9 : 1) was evaporated todryness. The lipid film was solubilized in 
150 mM OG. A sample containing 3, 10 or 30 gmol PL was added/ml 
solubilized membranes, which contained approximately 1.0 gmol PL 
extracted from the crude membranes. Purified reconstituted membranes 
were obtained as described above. 
Electron microscopy. Electron microscopy of reconstituted membranes 
was performed by Dr. J. R6ding at the laboratories ofNattermann Phos- 
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analysed for protein ( 9 ) and phospholipid ( [] ) content. B Membrane 
proteins were separated from lipids by gel filtration ofsolubilized mem- 
brane proteins and were subsequently subjected to the r~onstitution a d 
floatation procedure as described for A. C Lipids were obtained from 
SL2 c lls by repeated chloroform/methanol extraction and were sub- 
jected to the reconstitution and floatation procedure as described for A 
pholipid GmbH, Cologne, Germany. Micrographs were obtained after 
cryofixation of the dispersions on the grid. 
Analytical assays. The protein content was assessed by the method f
Wessel and Fltigge [39] using bovine serum albumin type V (Sigma 
Chemical Co., St. Louis, Mo.) as a standard. Lipid phosphorus was 
determined by the colorimetric method of Fiske and Subbarow [ 14] after 
lipid extraction with chloroform/methanol according to the method of 
Bligh and Dyer [5]. Mean particle size and polydispersity were measured 
by dynamic light scattering with a Malvern 4700 system using a 25-roW 
helium/neon laser and the automeasure version 3.2 software (Malvern 
Ltd., Malvern, UK). The distribution of particle sizes was quantified 
using the polydispersity index. This index ranges from 0.0 for an entirely 
monodisperse preparation up t  1.0 for a completely polydisperse prepa- 
ration. Sodium dodecylsulphate/polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed according to Laemmli [24] with some 
modifications described by Jiskoot et al. [22]. Protein was visualized by 
Coomassie brilliant blue staining. 
Immunization9 DBA/2 mice were immunized by two s. c. injections with 
presumptive antigen in a total volume of 0.20 ml on the chest on days 
-30, -20 and -10. On day 0, mice were challenged i.p. with 103 viable 
SL2 cells. Survival of mice was monitored daily. The cellular equivalent, 
that is the amount of protein that can be extracted from a fixed number of 
tumour cells, was assessed from initial experiments. 
Statistical nalysis. Differences insurvival times of groups of mice were 
analysed by the non-parametric Wilcoxon rank-sum test. Student's t-test 
was used to test the significance of differences inthe percentage protein 
associated with the reconstituted membranes. 
Results  
Characteristics and purification of reconstituted 
membranes 
Crude cell membranes of SL2 cells were solubil ized with 
OG and non-solubi l ized material was removed by centrifu- 
gation. In a typical experiment, OG solubilized about 40% 
of the membrane proteins and about 80% of the phos- 
Fig. 2. Electron micrograph (cryofixation) of SL2 reconstituted mem- 
branes. Scale bar represents 0.2 gm 
pholipids. Proteins and lipids were allowed to reassociate 
i to membranes by removal of the detergent. Initial charac- 
terization of these reconstituted membranes has been de- 
scribed before. Proteins solubilized by OG were separated 
by SDS-PAGE, and patterns in different runs were com- 
pared with those given by the crude membrane proteins. At 
least 35 different protein bands could be distinguished in
the membrane samples. Both the solubilized membranes 
and the reconstituted membranes exhibited about 18 pro- 
tein bands; these were also present in the crude mem- 
branes. Especially proteins with a low electrophoretic mo- 
bility were not solubilized by OG. Storage of membranes 
or reconstituted membranes at-20  ~ C for 3 months did not 
produce alterations in the mobil ity pattern. 
Reconstituted membranes were purified by floatation in 
a discontinuous sucrose gradient o remove proteins that 
were not associated with the membranes. A typical elution 
profile of proteins and PL is shown in Fig. 1 A. Approxi- 
mately 30% of the proteins and 90% of the PL were recov- 
ered in the upper three fractions. When reconstitution was 
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Tab le  1. Characteristics of reconstituted membranes and purified re- 
constituted membranes u ed for the immunization studies 
Ratio protein/PL reconstituted membranes 
(mg/gmol) a 0.8 _+ 
Ratio protein/PL purified reconstituted 
membranes (mg/gmol) ~ 0.34_+ 0.05 
Protein recovered inthe purified 
reconstituted membranes (%)d 31 _+ 5 
Protein recovered inthe remaining 
fraction (%)d 62 _+ 11 
Mean particle size of reconstituted 
membranes (gm) e 0.14 + 0.02 
Polydispersity index of reconstituted 
membranes , f 0.2 - 0.3 
Mean particle size of purified reconstituted 
membranes (gin) e 0.16 _+ 0.02 
Polydispersity index of purified 
reconstitutedmembranese, f 0.3 - 0.4 
Protein in remaining fraction that could not 
be pelleted (%)g 72 + 8 
0.1 b (n = 10) 
(n = 9) 
(n = 21) 
(n = 21) 
(n = 19) 
(n = 16) 
(n= 5) 
a PL, phospholipid; SL2 membranes (protein/PL ratio of 
1.6 _+ 0.1 mg/gmol) were solubilized with octylglucoside and reconsti- 
tuted membranes were obtained by detergent removal 
b Mean _+ standard eviation 
~ Reconstituted membranes were centrifuged ina discontinuous sucrose 
gradient. The amount of protein and phospholipid were measured in the 
pooled upper three fractions 
d Expressed as the amount of protein measured in this fraction com- 
pared to the amount of protein applied to the gradient. Protein recovery 
was 99_+ 11% 
e Determined with dynamic light scattering 
f This index ranges from 0.0 to 1.0; 0.0 denotes amonodisperse and 1.0 
an extremely polydisperse ystem 
g The remaining fraction was centrifuged at 250000 g for 2 h and the 
amount of protein in the supernatant was determined 
performed with only proteins and this material  was run in a 
sucrose gradient, 100% of the proteins remained at the 
bottom of the gradient (Fig. 1 B). Centrifugation of re- 
constituted membranes consisting mainly of  SL2 mem- 
brane l ipids in a sucrose gradient resulted in f loatation of  
all the PL (Fig. 1 C). This was also observed for empty 
l iposomes composed of  PtdCho/PtdGro (9:1)  (data not 
shown). 
Therefore, the proteins in the upper three fractions were 
considered to be associated with the reconstituted mem- 
branes prepared from the cell membrane lipids. After re- 
centrifugation of the pooled three upper fractions in a dis- 
continuous sucrose gradient, the proteins were quantita- 
t ively recovered in these fractions (data not shown). This 
impl ies that the proteins are stably associated with the 
reconstituted membranes and that these fractions are not 
contaminated with proteins that are not associated with the 
reconstituted membranes.  
An electron micrograph (made after cryof ixat ion on the 
grid) of the reconstituted membranes obtained from the 
pooled upper three fractions is shown in Fig. 2. The re- 
constituted membranes consisted of  l iposomal structures 
with a spherical shape and with diameters ranging from 
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Fig. 3A, B. Induction of protective tumour immunity by immunization 
with purified reconstituted membranes. Reconstituted membranes pre- 
pared from SL2 membranes were centrifuged ina discontinuous sucrose 
gradient. The reconstituted membranes (pooled fractions 1-3; see 
Fig. 1A) and the remaining fraction (pooled fractions 6-11; see 
Fig. 1 A) were collected, dialysed, and concentrated. Furthermore, the 
remaining fraction was centrifuged at 250 000 g for 2 h to spin down any 
particulate material present. Mice were immunized three times s.c. (10- 
day intervals). Ten days after the last immunization the animals were 
challenged i.p. with 103 SL2 cells. Protein dose (cellular equiv- 
alents)/immunization: A 40 gg (2.5 x 107) purified reconstituted mem- 
branes (1, ...); 16 gg (1.0 x 107) purified reconstituted membranes (2, 
- - - ) ;  4 gg (2.5 x 106) purified reconstituted membranes (3, - . - )  
125 gg (2.5 x 107) reconstituted membranes (4, - -  ); no immunization 
(5, --);  B 75 gg (2.5 x 107) remaining fraction (1, ..-); 30 gg (1.0 x 10 7) 
remaining fraction (2, - - -); 8 gg (2.5 x 106) remaining fraction (3, 
--  - ); 50 gg (2.5 x 107) supematant after pelleting particulate material of 
the remaining fraction (4, - - ) ;  no immunization (5, --).  10-15 
mice/group 
0.03 gm to 0.15 p+m. About 95% of the vesicles were uni- 
lamellar. 
The physical  nature of the remaining (bottom) fractions 
(fractions 6 -11 ;  fractions 4 and 5 were discarded) is less 
clear. About  10% of the PL of  the reconstituted membranes 
appl ied to the sucrose gradient was found in these frac- 
tions. After removal  of  sucrose, 72_+8% (n = 5) of  the 
proteins present in these fractions could not be pel leted by 
centrifugation at 250000 g for 2 h. No PL could be de- 
tected in the supernatant. This implies that, apart from 
"soluble" proteins, protein-containing particles with a rela- 
t ively high density, probably protein-(l ipid) aggregates 
and/or l iposomes with a relatively high protein content 
and, consequently, a relat ively high density [9, 12], are 
present in the bottom fractions. The characteristics of re- 
constituted membranes used for the in vivo experiments 
are summarized in Table 1. 
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Fig. 4. Effect of the presentation form on the immunogenicity of SL2 
membrane antigens. Reconstituted membranes prepared from SL2 mem- 
branes were purified by centrifugation i a discontinuous sucrose gradi- 
ent. The immunization schedule was the same as that described in Fig. 3. 
Protein dose/immunization was 16 gg. Purified reconstituted membranes 
(1, - - - ) ;  purified reconstituted membranes olubilized in 40 mM 
octylglucoside (2, ...); 40 mM octylglucoside only (3, - - - ) ;  no immuni- 
zation (4, - - ) .  10-20 mice/group 
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Table 2. Effect of trypsin treatment on the protective turnour immunity 
induced by purified reconstituted membranes 
Type of preparation used for Surviving mice MST_+ SD ~ 
immunization s at day 40 b (days) 
Purified reconstituted membranes d 5/15 
Purified reconstituted membranes treated 
with trypsin e 0/15 20 _+ 2 
None 0/10 20_+2 
a Immunization schedule was the same as that described in Fig. 2 
b Number of animals alive at day 40/total number of animals 
c Mean survival time _+ standard eviation 
d Dose was 40 gg protein/immunization, corresponding to 125 btg re- 
constituted membranes 
e Solubilized membranes were treated with trypsin at 37 ~ C for 2 h and 
the detergent was removed. The reconstituted membranes were centri- 
fuged in a discontinuous sucrose gradient. The fractions containing re- 
constituted membranes were removed, dialysed, and concentrated. The 
amount administered per Lmmnnization corresponded to 125 btg reconsti- 
tuted membranes 
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Fig. 5. Comparison of the immunoprotective effects of various prepara- 
tions of SL2 cells on the basis of protein. For the preparation method and 
immunization schedule see Fig. 3. Protein dose/immunization was 
16 gg. 1.5 • 105 SL2 ceils irradiated with 50 Gy y irradiation (1, ...); 
crude membranes (2, - - ) ;  reconstituted membranes (3, - . - ) ;  purified 
reconstituted membranes (4, - - - ) ;  no immunization (5, - - ) .  10 
mice/group 
Protective tumour immunity induced by purified 
reconstituted membranes 
The potential to induce protection against achallenge with 
103 SL2 cells was determined for (a) reconstituted mem- 
branes, (b) purified reconstituted membranes (the pooled 
fractions 1-3 shown in Fig. 1A), (c) the remaining frac- 
tion (the pooled fractions 6-11 shown in Fig. 1 A), and (d) 
the supernatant after particulate material present in the 
remaining fraction had been pelleted. DBA/2 mice were 
immunized three times s.c. (10-day intervals). Ten days 
after the last immunization, mice were challenged i. p. with 
103 syngeneic viable tumour cells. The results, depicted in 
Fig. 3, show that all non-immunized mice died within 
22 days. Mice immunized with 2.5 x 107 cellular equiv- 
alents of reconstituted membranes (125 btg protein), puri- 
fied reconstituted membranes (40 gg protein), or the re- 
maining fraction (75 btg protein) survived significantly 
longer than non-immunized mice (P <0.01 for all three 
comparisons). Between 20% and 60% of the animals sur- 
vived for more than 90 days. These animals had no visible 
tumour and were considered cured. Immunization of mice 
with purified reconstituted membranes tended to be better 
than immunization with the remaining fraction, but the 
differences in survival were not statistically significant at 
any of the three dose levels tested (P >0.05, compared on 
the basis of cellular equivalents). Mice immunized with the 
remaining fraction devoid of particulate material could not 
reject he challenge with SL2 cells; all these animals died 
within 21 days after tumour challenge. This demonstrates 
that the protection i duced by the remaining fraction is not 
induced by soluble proteins or small protein micelles, but 
by particulate material with a relatively high density. 
Effect of the presentation vehicle of membrane antigens 
on the induction of protective tumour immunity 
The effect of the presentation form of SL2 TAA (inserted 
in a membrane structure or presented as a detergent-protein 
complex) on the induction of tumour immunity was stud- 
ied (Fig. 4). Therefore, purified reconstituted membranes 
were solubilized in 40 mM OG at a final protein concentra- 
tion of 80 gg/ml. The protection elicited by immunization 
with these solubilized membranes was significantly 
decreased with regard to the intact, purified, reconstituted 
membranes (P <0.05). No significant differences in sur- 
vival were found between groups of mice treated with the 
solubilized reconstituted membranes and treated with the 
solubilizing agent (OG) only. Subcutaneous. administration 
of the preparations containing OG caused inflammatory 
reactions at the injection sites, which were observed mac- 
roscopically and confirmed by microscopical examination. 
Such reactions were not seen after injections with reconsti- 
tuted membranes. Usually all non-immunized mice died 
within 25 days after i.p. injection of 103 SL2 cells. Non- 
specific increase in the resistance through the administra- 
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Fig. 6. Effect of the addition of exogenous phospholipid (PL) on the 
reconstitution efficiency of SL2 membrane proteins. Crude SL2 mem- 
branes were solubilized with octylglucoside and the indicated amount of 
phospholipid (phosphatidylcholine/phosphatidylglycerol at a ratio of 
9 : 1) was added. After detergent removal, the reconstituted membranes 
were centrifuged in a discontinuous sucrose gradient. The percentage 
protein associated with the reconstituted membranes was calculated from 
the amount of protein in the upper three fractions of the gradient derided 
by the amount of protein applied. Error bars indicate standard eviations 
(five experiments) 
than immunization with crude membranes (P <0.05). The 
protection induced by reconstituted membranes that were 
purified by floatation in sucrose gradients tended to be 
lower than the protection induced by the non-purified re- 
constituted membranes, but this reduction was not statisti- 
cally significant. 
Trypsin treatment of solubilized membrane proteins 
To determine whether the immunoprotective activity ob- 
served with reconstituted membranes could be attributed to 
(glyco)proteins, solubilized membranes were treated with 
the proteolytic enzyme trypsin. Reconstituted membranes 
were formed by removal of the detergent and were purified 
by floatation in a discontinuous sucrose gradient to remove 
trypsin. No protection against a challenge with SL2 cells 
was observed after immunization of mice with the trypsin- 
digested preparations; immunization of mice with non- 
trypsinized purified reconstituted membranes elicited sig- 
nificant protection (P <0.05) (Table 2). 
tion of OG may account for the animal that rejected the 
tumour in the group treated with OG only and, con- 
sequently, for the animal that died at day 77 in the group 
treated with membranes solubilized in OG. 
Protective tumour immunity induced by different 
preparations of SL2 cells 
Results of experiments in which the immunogenicities of 
irradiated tumour cells, crude membranes, reconstituted 
membranes, and purified reconstituted membranes were 
compared on the basis of equal protein doses (16 gg/immu- 
nization) are shown in Fig. 5. Immunization of mice with 
1.5 x 105 irradiated SL2 cells induced protection against a 
challenge with 103 SL2 cells. The immunoprotective activ- 
ity of equal doses of crude membrane proteins was signifi- 
cantly less (P <0.01). However, immunization with re- 
constituted membranes was significantly more effective 
Reconstituted membranes containing additional 
exogenous phospholipid 
The effect of the addition of exogenous PL on the charac- 
teristics and the immunogenicity of reconstituted mem- 
branes was studied. To solubilized SL2 membranes, differ- 
ent amounts of PtdCho/PtdGro (9: 1), also solubilized in 
OG, were added. After dialysis, the reconstituted mem- 
branes were purified by floatation in sucrose gradients. The 
percentage protein recovered in the upper three fractions 
increased significantly (P <0.01) from 31% (no exogenous 
PL) to 48% (addition of 30 gmol exogenous PL/ml solubi- 
lized membranes) (Fig. 6). 
The distribution of proteins and PL of reconstituted 
membranes and of reconstituted membranes with 30 ~tmol 
PL/ml solubilized membranes in a continuous sucrose gra- 
dient is shown in Fig. 7. For each sucrose density gradient 
profile, the protein-to-PL ratio increased with increasing 
density. Maximal concentrations of PL were found in frac- 
tions 3-5 (density 1.06-1.13) for reconstituted mem- 
branes and in fraction 1 (density 1.02) for reconstituted 
A: without exogenous phospholipid B: with exogenous phospholipid 
. . . . . .  ' ' ' ' ~ [1 .3  ' ~ ~ ' ~ ' ~ ' ' ' ' ' 1 .3  
I 
7 ~,,~...o--...,o--.-.-~ .- . ~'1.2 
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1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10 
ml from top of the gradient ml from top of the gradient 
Fig. 7 A, B. Floatation of reconstituted mem- 
branes and reconstituted membranes with exo- 
genous phospholipid n a continuous sucrose 
gradient. Reconstituted membranes (A) and re- 
constituted membranes prepared with 30 gmol 
exogenous phospholipid/ml solubilized mem- 
branes (B) were applied to the bottom of a con- 
tinuous ucrose gradient. After centrifugation 
for 16 h, 1-ml fractions were collected from 
the top of the gradient and analysed for protein 
( 9 ) and phospholipid ( [] ) content. O, Den- 
sity. Typical experiment out of two performed 
is shown 
Table 3. Protective turnout immunity induced by immunization with 
purified reconstituted membranes containing additional exogenous phos- 
pholipids 
Purified reconstituted membranes a 
Phospholipid added Injected 
(~tmol/ml solubilized phospholipid 
membranes) dose (gmol) 
Surviving mice at day b 
40 90 
0 0.1 5/13 (38) 4/13 (31) 
3 0.5 4/10 (40) 3/10 (30) 
10 1.3 3/10 (30) 2/10 (20) 
30 2.5 2/15 (13) 2/15 (13) 
a Reconstituted membranes were prepared with the indicated amount of 
phospholipid (phosphatidylcholine/phosphatidylglycerol ratio f 9: 1) 
and centrifuged in a discontinuous sucrose gradient. The upper three 
fractions containing the purified reconstituted membranes were pooled, 
dialysed and concentrated. Mice were immunized three times s.c. (10- 
day intervals) with 40 ~tg protein and challenged i.p. with 3 x 102 SL2 
cells 10 days after the last immunization 
b Number of animals alive at the day indicated/total number of animals 
(% within parentheses). Naive control mice injected with the same 
tumour challenge died within 25 days 
membranes with exogenous PL. Thus, addition of exo- 
genous PL resulted in an increased number of vesicles with 
a relatively low protein content. However, the density pro- 
files also indicate that the purified reconstituted mem- 
branes used for the immunization studies contained ves- 
icles with a variety of protein-to-PL ratios. This may also 
apply to the unpurified reconstituted membranes, although 
the osmotic pressure produced by the high sucrose concen- 
trations may affect the vesicle structure during gradient 
centrifugation. A slight increase in mean particle size and 
polydispersity index of the reconstituted membranes was 
generally observed after purification by floatation in the 
discontinuous sucrose gradients (Table 1). 
Mice were immunized with purified reconstituted mem- 
branes and purified reconstituted membranes with 3, 10 or 
30 gmol exogenous PL. No significant differences were 
found in the potential of these preparations to induce pro- 
tective tumour immunity (Table 3). 
Discuss ion  
TAA were extracted from crude membranes of SL2 cells 
and subsequently associated with additional extracted PL 
to form a membrane-like, well-defined presentation vehi- 
cle. Substantial attention was paid to a proper physico- 
chemical characterization of these reconstituted mem- 
branes. Although this method has often been used for re- 
constitution of major histocompatibility antigens and viral 
proteins [6], it has not been explored before for tumour 
vaccine preparation. The reconstituted membranes were 
more immunogenic n terms of induction of protection than 
crude membranes when compared on the basis of protein 
dose (Fig. 5). 
For the extraction of proteins and lipids from SL2 cells 
OG was employed. This detergent solubilizes electively 
about 40% of the SL2 membrane proteins, including the 
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supposed TAA. On SDS-PAGE, the protein bands of the 
reconstituted membrane samples were also found in the 
crude membrane samples. Upon storage of membranes and 
reconstituted membranes at -20 ~ C, no alterations in the 
protein pattern were seen over 3 months. This indicates 
that major proteolytic degradation of proteins does not 
occur under these circumstances. Proteolytic degradation 
of proteins during extraction and upon storage has been 
reported for 3 M KC1 extracts [31]. As freezing/thawing of 
reconstituted membranes can induce changes in vesicle 
structure, they were not stored in frozen condition, but 
freshly prepared for each immunization. 
Reconstitution of the membrane proteins with the PL 
from the membranes cosolubilized has the advantage that 
- besides the simplicity of the method - the mixture of 
lipids is more likely to contain any essential lipids or to 
approximate closely any particular lipid requirement than 
would a defined mixture of highly purified lipids [8]. This 
may result in higher reconstitution efficiencies. For in- 
stance, Hudson et al. [20] reported apoor reconstitution of
Plasmodium knowlesi merezoite antigen into liposomes 
containing a synthetic PL, but the antigen was reconsti- 
tuted effectively by liposomes containing the same PL 
composition that was previously reported to be present in 
P. knowlesi. 
It was reported earlier [3] that about 50% of the proteins 
present in the reconstituted membrane preparation could be 
pelleted by high-speed centrifugation. Centrifugation 
caused aggregation of the vesicles. It was not possible to 
resuspend the pelleted vesicles to assess their immuno- 
genic properties. Therefore, in the present study, reconsti- 
tuted membranes were purified by floatation in a discon- 
tinuous ucrose gradient, and divided into two fractions for 
immunoprotection studies. About 30% of the proteins and 
90% of the PL applied to the gradient were recovered inthe 
upper fraction, containing proteins associated with re- 
constituted membranes (fractions 1-3 in Fig. 1 A). Protec- 
tion studies indicated that this fraction contained a consid- 
erable amount of immunogenic material. However, immu- 
nization of mice with the remaining (bottom) fraction 
(fractions 6-11 in Fig. 1A) elicited protection as well. 
Analysis of this fraction revealed that about 28% of the 
proteins present in this fraction could be pelleted by high- 
speed centrifugation. Immunization of mice with the re- 
maining fraction after removal of particulate material did 
not affect turnout growth. Therefore, it can be concluded 
for the (unpurified) reconstituted membranes that particu- 
late material is essential for the induction of immune re- 
sponses. A major part of the immunogenic activity of this 
particulate material can be attributed to proteins associated 
with the reconstituted membranes. Soluble material is not 
very immunogenic by itself, although such material present 
in the reconstituted membranes may contribute to the im- 
munological response. An additional effect of free protein 
on the immune response induced by liposome-associated 
protein has been reported by Ho et al. [18] for herpes 
simplex virus glycoprotein D. 
Purified reconstituted membranes presented ina solubi- 
lized form were not immunogenic (Fig. 4). As a high deter- 
gent-to-protein ratio was used (150:1 by weight) this prep- 
aration contained probably protein-detergent complexes 
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and lipid-detergent mixed micelles [17] instead of lipo- 
somal structures. These results resemble the low immuno- 
genicity of protein-detergent complexes of spike glyco- 
proteins of virus envelopes [1, 28]. This has been ascribed 
to the monomeric form of the protein-detergent complex; 
presentation of spike glycoproteins in multimeric forms 
(viruses, liposomes, protein micelles) was far more effec- 
tive. Supersaxo et al. [37] showed that following s. c. injec- 
tion of drug/PtdCho/bile salt mixed micelles, the micelles 
were converted in vivo into liposomes, probably because 
of a combined effect of dilution and dialysis. Drugs with a 
high lipophilicity were associated with the newly formed 
liposomes. This mechanism is not likely to occur after 
injection of the solubilized reconstituted membranes, as a 
high detergent-to-protein ratio and very low doses of pro- 
tein and PL were employed. Injection of the OG-solubi- 
lized membrane proteins or only OG caused severe inflam- 
mation at the injection site, leading to ulceration. These 
results show that detergent removal is required to obtain 
specific stimulation of immune responses by SL2 mem- 
brane TAA and to avoid the toxicity associated with the 
detergent. 
The experiments concerning the addition of exogenous 
PL to the solubilized membranes were performed for two 
reasons. First, addition of exogenous PL might increase the 
reconstitution efficiency as determined by sucrose gradient 
centrifugation. Studies on the reconstitution of purified 
hydrophobic proteins (e. g. rhodopsin, maj or histocompati- 
bility antigens, viral antigens) into liposomes have shown 
that much lower protein-to-PL ratios are required for re- 
constitution than are present in biological membranes [ 13]. 
The exact reason is not understood. The reconstitution 
efficiency of solubilized SL2 crude membrane proteins, 
with an initial protein-to-PL ratio of 0.8 mg/gmol, 
increased slightly on the addition of exogenous 
PtdCho/PtdGro to a protein-to-PL ratio of 0.03 mg/gmol 
(Fig. 6). 
Second, the protein-to-PL ratio may affect he immuno- 
genicity of liposome-presented antigens, as described for 
the humoral response against protein antigens [10, 38]. 
Liposomal incorporation of crude or semi-purified TAA 
extracts can augment specific immune reactions against 
TAA [16, 25, 30, 33, 34]. In these studies a variety of 
tumour models, extraction techniques, and liposome types 
has been employed. They have in common that the lipo- 
somes contained much lower protein-to-PL ratios (gener- 
ally between 0.01 and 0.04 mg/gmol) than the reconsti- 
tuted membranes (0.3 mg/gmol) used in the study pre- 
sented here. Consequently, higher PL doses are required to 
inject an equal dose of protein. It is possible that liposomes 
with a low protein-to-PL ratio may induce enhanced im- 
mune responses, either by a low concentration fantigen in 
individual vesicles or by the mass of injected liposomal 
lipid. Reconstitution of SL2 membrane proteins with addi- 
tional PL resulted only partially in liposomes with a lower 
protein content. Floatation of the liposomes in continuous 
sucrose gradients revealed that protein-rich liposomes exist 
next to protein-poor liposomes (Fig. 7). This phenomenon 
is not exclusively for reconstitution of crude mixtures of 
membrane proteins. Several investigators have reported a
non-random distribution of purified proteins in liposome 
dispersions [e. g., 12, 21]. In the publications mentioned 
above on TAA extracts in liposomes, the homogeneity of
the dispersions was not described. No major differences in 
the immune responses elicited by reconstituted membranes 
and reconstituted membranes with additional PL were ob- 
served in the present study. 
Almost all the immunoprotective TAA that have been 
identified up to now are (glyco)proteins [35]. (Glyco)pro- 
teins were the essential TAA in the reconstituted mem- 
branes as well, as digestion of SL2 membrane proteins 
with trypsin destroyed the ability to induce protection. This 
is consistent with the earlier observation that mice im- 
munized with reconstituted membranes mainly consis- 
ting of lipids or with semi-purified glycolipids of SL2 
cells incorporated into liposomes could not reject the 
tumour [3]. 
In conclusion, membrane presentation of TAA on re- 
constituted membranes obtained by solubilization of crude 
SL2 membranes with OG, and subsequent removal of the 
detergent, is more effective in terms of the induction of 
immunoprotection than presentation of TAA on crude 
membranes. Detergent removal is critical for the induction 
of protective immune responses. Although the dispersion 
showed a degree of heterogeneity, the procedures de- 
scribed here may be a good starting-point to obtain 
strongly immunogenic TAA following a standard prepara- 
tion procedure as: (a) peripheral and transmembrane pro- 
teins and glycolipids are obtained with minimal contami- 
nation with intracellular proteins, (b) OG is a "gentle", 
non-ionic detergent, causing minimal protein denaturation; 
OG can be easily removed by dialysis, (c) proteins olubi- 
lized by OG can be further purified in the "solubilized 
state", (d) antigens are presented on a membrane-like 
structure, which also allows evaluation of membrane fac- 
tors and of accessory molecules necessary for the induction 
of immune responses, (e) injection of toxic detergent is
prevented, and (f) amphipathic adjuvants may be co-incor- 
porated into the reconstituted membranes to enhance the 
induced immune response. They may provide an alterna- 
tive for whole-cell vaccines in immunotherapeutic trials 
and for studying the interaction of TAA with cells of the 
immune system in order to manipulate immune responses, 
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